Venn Life Sciences Holdings PLC: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Venn Life Sciences Holdings Plc announces placing to raise 1 mln pounds
Venn Life Sciences Holdings Plc:Placed 5,263,158 new ordinary shares, through Zeus Capital as broker.Placing price of 19 pence per ordinary share with investors to raise 1 mln pounds before expenses.Intends to use the net proceeds to develop the opportunities provided by the recent acquisition of Labskin and the SYN1113 intellectual property rights.
Latest Developments for Venn Life Sciences Holdings PLC
- Venn Life Sciences Holdings PLC announces acquisition of Belfast based CRO
- Venn Life Sciences Holdings PLC Announces Launch of Innovation Division and Co-Development Initiative
- Venn Life Sciences Holdings PLC Announces Senior Management Appointments
- Venn Life Sciences Holdings PLC Establishes Joint Venture in Russia
Latest Key Developments in Investment
- International Public Partnerships Ltd divests stake in French PPP investment
- Tuckamore announces termination of arrangement agreement with Triumph Acquisition LP and provides update on strategic plan
- Securities Trust Of Scotland PLC declares first interim dividend
- Argent Energy Trust revises FY 2014 production guidance; raises Q3 2014 production guidance
- Share this
- Digg this